ashland inc. - ASH

ASH

Close Chg Chg %
62.35 1.54 2.46%

Open Market

63.89

+1.54 (2.46%)

Volume: 177.68K

Last Updated:

Jan 12, 2026, 11:43 AM EDT

Company Overview: ashland inc. - ASH

ASH Key Data

Open

$61.99

Day Range

61.87 - 64.22

52 Week Range

45.29 - 73.39

Market Cap

$2.85B

Shares Outstanding

45.76M

Public Float

45.13M

Beta

0.42

Rev. Per Employee

N/A

P/E Ratio

N/A

EPS

-$18.26

Yield

264.68%

Dividend

$0.42

EX-DIVIDEND DATE

Dec 1, 2025

SHORT INTEREST

N/A

AVERAGE VOLUME

716.63K

 

ASH Performance

1 Week
 
4.16%
 
1 Month
 
5.39%
 
3 Months
 
31.21%
 
1 Year
 
-9.55%
 
5 Years
 
-26.64%
 

ASH Analyst Ratings

  • Sell
  • Under
  • Hold
  • Over
  • Buy
Number of Ratings 11
Full Ratings ➔

About ashland inc. - ASH

Ashland, Inc. is an additives and specialty ingredients company, which engages in the provision of architectural coatings, construction, energy, food and beverage, nutraceuticals, personal care, and pharmaceutical products. It operates through the following segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. The Life Sciences segment is involved in pharmaceuticals, nutrition, nutraceuticals, agricultural chemicals, diagnostic films, and fine chemicals. The Personal Care segment consists of biofunctionals, microbial protectants, skin care, sun care, oral care, hair care, and household solutions. The Specialty Additives segment focuses on rheology and performance-enhancing additives serving the architectural coatings, construction, energy, automotive, and various industrial markets. The Intermediates segment refers to production of 1,4 butanediol and related derivatives, including n-methylpyrrolidone. The company was founded in 1924 and is headquartered in Wilmington, DE.

ASH At a Glance

Ashland, Inc.
8145 Blazer Drive
Wilmington, Delaware 19808
Phone 1-302-995-3000 Revenue 1.82B
Industry Food: Specialty/Candy Net Income -845,000,000.00
Sector Consumer Non-Durables Employees 2,900
Fiscal Year-end 09 / 2026
View SEC Filings

ASH Valuation

P/E Current N/A
P/E Ratio (with extraordinary items) N/A
P/E Ratio (without extraordinary items) N/A
Price to Sales Ratio 1.208
Price to Book Ratio 1.157
Price to Cash Flow Ratio 16.45
Enterprise Value to EBITDA 8.883
Enterprise Value to Sales 1.88
Total Debt to Enterprise Value 0.435

ASH Efficiency

Revenue/Employee 628,965.517
Income Per Employee -291,379.31
Receivables Turnover 7.537
Total Asset Turnover 0.356

ASH Liquidity

Current Ratio 2.849
Quick Ratio 1.506
Cash Ratio 0.626

ASH Profitability

Gross Margin 23.958
Operating Margin 5.373
Pretax Margin -44.353
Net Margin -46.327
Return on Assets -16.03
Return on Equity -34.451
Return on Total Capital -24.219
Return on Invested Capital -21.381

ASH Capital Structure

Total Debt to Total Equity 78.256
Total Debt to Total Capital 43.901
Total Debt to Total Assets 32.314
Long-Term Debt to Equity 77.153
Long-Term Debt to Total Capital 43.282
  • Income Statement
  • Balance Sheet
  • Cash Flow Statement

Annual Financials for Ashland Inc. - ASH

Collapse All in section
All values USD millions. 2022 2023 2024 2025 5-year trend
Sales/Revenue
2.39B 2.19B 2.11B 1.82B
Sales Growth
+13.26% -8.36% -3.56% -13.68%
Cost of Goods Sold (COGS) incl D&A
1.72B 1.67B 1.62B 1.39B
COGS excluding D&A
- - - -
-
Depreciation & Amortization Expense
308.00M 300.00M 329.00M 288.00M
Depreciation
214.00M 207.00M 253.00M 225.00M
Amortization of Intangibles
94.00M 93.00M 76.00M 63.00M
COGS Growth
+12.48% -3.02% -2.99% -14.38%
Gross Income
669.00M 521.00M 493.00M 437.00M
Gross Income Growth
+15.34% -22.12% -5.37% -11.36%
Gross Profit Margin
+27.98% +23.78% +23.33% +23.96%
2022 2023 2024 2025 5-year trend
SG&A Expense
337.00M 353.00M 378.00M 339.00M
Research & Development
55.00M 51.00M 55.00M 54.00M
Other SG&A
282.00M 302.00M 323.00M 285.00M
SGA Growth
-14.68% +4.75% +7.08% -10.32%
Other Operating Expense
- - - -
-
Unusual Expense
44.00M 9.00M 32.00M 716.00M
EBIT after Unusual Expense
288.00M 159.00M 83.00M (618.00M)
Non Operating Income/Expense
(16.00M) 58.00M (52.00M) (128.00M)
Non-Operating Interest Income
4.00M 12.00M 10.00M 5.00M
Equity in Earnings of Affiliates
- - - -
-
Interest Expense
66.00M 57.00M 55.00M 63.00M
Interest Expense Growth
-9.59% -13.64% -3.51% +14.55%
Gross Interest Expense
66.00M 57.00M 55.00M 63.00M
Interest Capitalized
- - - -
-
Pretax Income
206.00M 160.00M (24.00M) (809.00M)
Pretax Income Growth
+52.59% -22.33% -115.00% -3,270.83%
Pretax Margin
+8.62% +7.30% -1.14% -44.35%
Income Tax
25.00M (8.00M) (223.00M) 13.00M
Income Tax - Current - Domestic
10.00M (22.00M) 24.00M (96.00M)
Income Tax - Current - Foreign
50.00M 46.00M 55.00M 36.00M
Income Tax - Deferred - Domestic
(35.00M) (32.00M) (302.00M) 73.00M
Income Tax - Deferred - Foreign
- - - -
-
Income Tax Credits
- - - -
-
Equity in Earnings of Affiliates
- - - -
-
Other After Tax Income (Expense)
- - - -
-
Consolidated Net Income
181.00M 168.00M 199.00M (822.00M)
Minority Interest Expense
- - - -
-
Net Income
181.00M 168.00M 199.00M (822.00M)
Net Income Growth
+4.62% -7.18% +18.45% -513.07%
Net Margin Growth
+7.57% +7.67% +9.42% -45.07%
Extraordinaries & Discontinued Operations
(317.00M) 10.00M (30.00M) (23.00M)
Discontinued Operations
(317.00M) 10.00M (30.00M) (23.00M)
Net Income After Extraordinaries
(136.00M) 178.00M 169.00M (845.00M)
Preferred Dividends
- - - -
-
Net Income Available to Common
(136.00M) 178.00M 169.00M (845.00M)
EPS (Basic)
-2.4727 3.3585 3.449 -18.3696
EPS (Basic) Growth
-166.53% +235.82% +2.69% -632.61%
Basic Shares Outstanding
55.00M 53.00M 49.00M 46.00M
EPS (Diluted)
-2.4727 3.3585 3.38 -18.3696
EPS (Diluted) Growth
-167.64% +235.82% +0.64% -643.48%
Diluted Shares Outstanding
56.00M 54.00M 50.00M 46.00M
EBITDA
640.00M 468.00M 444.00M 386.00M
EBITDA Growth
+33.33% -26.88% -5.13% -13.06%
EBITDA Margin
+26.77% +21.36% +21.01% +21.16%

Snapshot

Average Recommendation OVERWEIGHT Average Target Price 65.20
Number of Ratings 11 Current Quarters Estimate 1.092
FY Report Date 03 / 2026 Current Year's Estimate 3.95
Last Quarter’s Earnings 0.25 Median PE on CY Estimate N/A
Year Ago Earnings 3.38 Next Fiscal Year Estimate 4.72
Median PE on Next FY Estimate N/A

Earnings Per Share

This Quarter Next Quarter This Fiscal Next Fiscal
# of Estimates 9 9 10 10
Mean Estimate 1.09 1.20 3.95 4.72
High Estimates 1.34 1.36 4.40 5.10
Low Estimate 0.77 0.96 3.58 4.00
Coefficient of Variance 15.98 9.71 6.30 7.02

Analysts Recommendations

Current 1 Month Ago 3 Months Ago
BUY 7 7 7
OVERWEIGHT 0 1 1
HOLD 4 4 5
UNDERWEIGHT 0 0 0
SELL 0 0 0
MEAN Overweight Overweight Overweight

Insider Actions for Ashland Inc. - ASH

Date Name Shares Transaction Value
Jul 29, 2025 Alessandra Faccin Assis SVP and GM, Life Sciences 6,273 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 Non-derivative transaction at $51.26 per share 321,553.98
Jul 29, 2025 Alessandra Faccin Assis SVP and GM, Life Sciences 4,946 Payment of exercise price or tax liability by delivering/withholding secs incident to the receipt/exercise/vesting pursuant to Rule 16b-3 Non-derivative transaction at $51.26 per share 253,531.96
Jul 29, 2025 Alessandra Faccin Assis SVP and GM, Life Sciences 12,498 Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 0.00
May 21, 2025 Samuel A. Richardson VP, Controller and PAO 2,516 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
May 20, 2025 William C. Whitaker Interim CFO and PFO 2,516 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 Steven D. Bishop Director 3,285 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Apr 2, 2025 Sanat Chattopadhyay Director 823 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 24, 2025 Susan Lee Main Director 13,624 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 24, 2025 Jerome A. Peribere Director 12,706 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 24, 2025 Suzan F. Harrison Director 5,947 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 24, 2025 Sérgio Messias Pedreiro Director 4,863 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 24, 2025 Scott A. Tozier Director 3,209 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00
Jan 24, 2025 Ashish K. Kulkarni Director 3,074 Grant, award or other acq pursuant to Rule 16b-3(d) 0.00

Ashland Inc. in the News